(Q38336284)

2 September 2017

title

Expression of tumor-promoting Cyr61 is regulated by hTRA2-β1 and acidosis (English)

1 reference

2 September 2017

3

1 reference

2 September 2017

4

Cristiana Stuani

1 reference

2 September 2017

Marc Hirschfeld

1

1 reference

2 September 2017

Markus Jaeger

2

1 reference

2 September 2017

Johannes Grueneisen

5

1 reference

2 September 2017

Gerald Gitsch

6

1 reference

2 September 2017

Elmar Stickeler

7

1 reference

2 September 2017

publication date

29 March 2011

1 reference

2 September 2017

published in

Human Molecular Genetics

1 reference

2 September 2017

volume

20

1 reference

2 September 2017

issue

12

1 reference

2 September 2017

page(s)

2356-2365

1 reference

Defective splicing, disease and therapy: searching for master checkpoints in exon definition.

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

Missed threads. The impact of pre-mRNA splicing defects on clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

The modular architecture of a new family of growth regulators related to connective tissue growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

Expression of cyr61, a growth factor-inducible immediate-early gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

All in the CCN family: essential matricellular signaling modulators emerge from the bunker

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

Functional properties and intracellular signaling of CCN1/Cyr61.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

The CCN family of angiogenic regulators: the integrin connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

CCN proteins and cancer: two to tango

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

cDNA microarray analysis of the gene expression profile of VEGF-activated human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

The angiogenic factor Cyr61 is induced by the progestin R5020 and is necessary for mammary adenocarcinoma cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

Alternative splicing of Cyr61 is regulated by hypoxia and significantly changed in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappaB-dependent XIAP up-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

Hypoxia--a key regulatory factor in tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

Acid-mediated tumor invasion: a multidisciplinary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

Hypoxia signalling controls metabolic demand

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

Microenvironment changes (in pH) affect VEGF alternative splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

Identification of eukaryotic mRNAs that are translated at reduced cap binding complex eIF4F concentrations using a cDNA microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

Re-programming of translation following cell stress allows IRES-mediated translation to predominate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

The evolving roles of alternative splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

Human tra2-beta1 autoregulates its protein concentration by influencing alternative splicing of its pre-mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

Human transformer-2-beta gene (SFRS10): complete nucleotide sequence, chromosomal localization, and generation of a tissue-specific isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

An alternative-exon database and its statistical analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

Cobalt inhibits the interaction between hypoxia-inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

Significance of nuclear hTra2-beta1 expression in cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

Structural basis for the dual RNA-recognition modes of human Tra2- RRM

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

Protein phosphatase 1 binds to the RNA recognition motif of several splicing factors and regulates alternative pre-mRNA processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

The splicing regulators Tra and Tra2 are unusually potent activators of pre-mRNA splicing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

Splicing of constitutive upstream introns is essential for the recognition of intra-exonic suboptimal splice sites in the thrombopoietin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

The doublesex splicing enhancer components Tra2 and Rbp1 also repress splicing through an intronic silencer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

hnRNP H binding at the 5' splice site correlates with the pathological effect of two intronic mutations in the NF-1 and TSHbeta genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDR128

21 January 2018

Identifiers

DOI

10.1093/HMG/DDR128

1 reference

2 September 2017

1 reference